Given that c-Myc regulates nucleolar assembly and aberrant expression of c-Myc promotes cancer cell growth through increase of ribosomal biogenesis [7–9], we hypothesized that OST-01-disrupted c-Myc regulated nucleolar structure and ribosome biogenesis is one of its antileukemic MOAs. Here, MYC is linked to cancer.